The development of endotension is associated with increased transmission of pressure and serous components in porous expanded polytetrafluoroethylene stent-grafts: characterization using a canine model.

OBJECTIVE This study used a canine model of abdominal aortic aneurysms (AAAs) to compare intra-aneurysmal pressure and thrombus formation after exclusion with Dacron and expanded polytetrafluoroethylene (ePTFE) stent-grafts. METHODS Prosthetic AAAs with implanted strain-gauge pressure transducers were treated by stent-graft exclusion using Food and Drug Administration-approved devices in 10 mongrel dogs: five Dacron (AneuRx) and five ePTFE (original Excluder). Intra-aneurysmal pressure was measured over 4 weeks after AAA exclusion and indexed to the systemic pressure, represented as a percentage of a simultaneously obtained systemic pressure (value = 1.0). Magnetic resonance imaging (MRI) of the intra-aneurysmal thrombus was performed at 1, 2, and 4 weeks after exclusion and expressed as a signal-to-noise ratio (S:N) to control for background signal intensity. Comparisons of pressures and S:N between the two stent-grafts was analyzed with the Student's t test. Intra-aneurysmal thrombus was characterized histologically. RESULTS In animals excluded with both Dacron and ePTFE stent-grafts, the intra-aneurysmal pressure was nonpulsatile and reduced to <30% of systemic pressure. Significantly greater pressure transmission was observed after AAA exclusion using ePTFE compared with Dacron stent grafts (systolic pressure: ePTFE, 0.28 +/- 0.12 vs Dacron, 0.11 +/- 0.02, P < .001; mean pressure: ePTFE, 0.16 +/- 0.08 vs Dacron, 0.06 +/- 0.02, P < .001). MRI confirmed the absence of perfusion in all aneurysms. The T1-weighted signal intensity remained persistently elevated (S:N at 1 week, 2.7 +/- 0.4 vs 2 weeks, 4.0 +/- 0.2 vs 4 weeks, 5.4 +/- 1.3) in ePTFE-treated intra-aneurysmal thrombus, suggesting an absence of thrombus organization. In contrast, progressive evolution of T1 signal intensity in aneurysms excluded by Dacron stent-grafts was consistent with maturation from intact red blood cells (S:N at 1 week, 3.3 +/- 0.4) to methemoglobin (S:N at 2 weeks, 6.1 +/- 0.8), and then hemosiderin and ferritin (S:N at 4 weeks, 2.4 +/- 0.5). Histologically, ePTFE-excluded aneurysms contained poorly organized thrombus with red blood cell fragments and haphazardly arranged fibrin deposition indicative of active remodeling and continued influx of transudated serum. In aneurysms excluded by Dacron stent-grafts, dense, mature collagenous connective tissue and organized fibrin were present, indicative of greater thrombus organization. CONCLUSIONS Stent-graft treatment reduces intra-aneurysmal pressure to <30% of systemic pressure when no endoleak is present; however, significantly greater pressure is present in aneurysms treated with porous ePTFE stent-grafts than Dacron grafts. Histologic and MRI imaging analysis suggest that active transudation of serous blood components may be contributing to this increased intra-aneurysmal pressure.

[1]  K. Ouriel,et al.  Endovascular repair of abdominal aortic aneurysms: device-specific outcome. , 2003, Journal of vascular surgery.

[2]  J. Reekers,et al.  Aortoesophageal Fistula Secondary to Mycotic Thoracic Aortic Aneurysm: Endovascular Repair and Transhiatal Esophagectomy , 2002, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[3]  S. Jern,et al.  Elevated intraluminal pressure inhibits vascular tissue plasminogen activator secretion and downregulates its gene expression. , 2000, Hypertension.

[4]  L. Lönn,et al.  Management of Aneurysm Sac Hygroma , 2004, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[5]  M. Makaroun,et al.  Late abdominal aortic aneurysm enlargement after endovascular repair with the Excluder device. , 2004, Journal of vascular surgery.

[6]  G. M. Williams,et al.  The management of massive ultrafiltration distending the aneurysm sac after abdominal aortic aneurysm repair with a polytetrafluoroethylene aortobiiliac graft. , 1998, Journal of vascular surgery.

[7]  Rodney A. White,et al.  Aneurysm enlargement following endovascular aneurysm repair: AneuRx clinical trial. , 2004, Journal of vascular surgery.

[8]  The Gore Excluder US multi-center trial: analysis of adverse events at 2 years. , 2003, Seminars in vascular surgery.

[9]  D. C. Brewster,et al.  Endovascular repair of abdominal aortic aneurysms: current status and future directions. , 2000, AJR. American journal of roentgenology.

[10]  J. May,et al.  Endotension : An explanation for continued AAA growth after successful endoluminal repair , 1999 .

[11]  P. Faries,et al.  Chronic intraaneurysmal pressure measurement: an experimental method for evaluating the effectiveness of endovascular aortic aneurysm exclusion. , 1997, Journal of vascular surgery.

[12]  V. Fuster,et al.  In vivo noninvasive detection and age definition of arterial thrombus by MRI. , 2002, Journal of the American College of Cardiology.

[13]  P. Faries,et al.  An Experimental Model for the Acute and Chronic Evaluation of Intra-Aneurysmal Pressure , 1997, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.

[14]  J. Sladen,et al.  Fibroblast inhibition: a new and treatable cause of prosthetic graft failure. , 1985, American journal of surgery.

[15]  J. May,et al.  Symptomatic sac enlargement and rupture due to seroma after open abdominal aortic aneurysm repair with polytetrafluoroethylene graft: Implications for endovascular repair and endotension. , 2004, Journal of vascular surgery.

[16]  L. Lönn,et al.  Aneurysm Sac Hygroma: A Cause of Endotension , 2001, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[17]  W. Bradley MR appearance of hemorrhage in the brain. , 1993, Radiology.